Infection | Antimicrobial regimen | % of key isolates covered (95% CI) |
---|---|---|
Sepsis/bloodstream infection (based on blood culture isolates) | Amoxicillin plus gentamicin | 76% (69% to 82%) |
Piperacillin/tazobactam | 73% (66% to 79%) | |
Ceftriaxone | 65% (58% to 72%) | |
Ceftriaxone or cefotaxime plus amoxicillin | 66% (59% to 73%) | |
Meropenem | 74% (68% to 81%) |
The cover estimates are based on data in table 2 and are presented with 95% CIs.